NATR — NATURES SUNSHINE PRODUCTS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 275053 ·
Last close
$12.92
Market Cap
$227.33M
52W High
$28.14
52W Low
$12.72
ADV30
170,810
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 116,985,000 | 86,174,000 | 5,481,000 | 3,538,000 | 259,823,000 | 82,503,000 | 90,507,000 |
| Mar 2026 | 122,892,000 | 89,977,000 | 9,545,000 | 5,118,000 | 261,458,000 | 87,578,000 | 94,542,000 |
| Dec 2025 | 123,807,000 | 89,779,000 | 5,322,000 | 4,107,000 | 261,146,000 | 93,891,000 | 99,593,000 |
| Sep 2025 | 128,339,000 | 94,049,000 | 8,975,000 | 5,334,000 | 264,805,000 | 95,554,000 | 98,101,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$30,866,000
Investing CF
$-7,850,000
Financing CF
$-24,621,000
CapEx
$-7,850,000
Dividends Paid
—
Buybacks
$-16,333,000
EPS Diluted TTM
$1.10
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$85,584,000
Inventory
$71,730,000
Receivables
$13,861,000
ST Investments
—
EBIT TTM
$28,821,000
Pretax Income TTM
$28,680,000
Interest Exp TTM
$141,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$492,023,008
EBITDA
$42,692,000
Free Cash Flow
$16,494,750
Enterprise Value
$177,344,288
Total Cash
$82,503,000
Total Debt
$21,428,000
Shares Out
17,595,520
Trailing EPS
$1.00
Book Value
$9.61
ROE
11.2%
ROA
7.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 480,144,000 | 24,743,000 | 19,521,000 | 261,146,000 | 99,593,000 | 161,553,000 | 35,321,000 |
| Dec 2024 | 454,364,000 | 20,095,000 | 7,696,000 | 240,855,000 | 79,864,000 | 155,313,000 | 25,298,000 |
| Dec 2023 | 445,320,000 | 18,749,000 | 15,076,000 | 249,773,000 | 90,233,000 | 154,058,000 | 41,226,000 |
| Dec 2022 | 421,910,000 | 16,258,000 | -390,000 | 229,778,000 | 82,731,000 | 142,905,000 | 710,000 |
TTM Snapshot
Revenues TTM
$440,105,000
NetIncome TTM
$13,010,000
OpCashFlow TTM
$0
Assets (Latest)
$240,855,000
Forward EPS
$1.23
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.50 · spot: $12.83 · call volume: 9 · put volume: 32Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | $228.18M | $31.41 | — |
| KROS | Keros Therapeutics, Inc. | $230.39M | $11.62 | — |
| RNAC | Cartesian Therapeutics, Inc. | $224.19M | $7.41 | — |
| PRQR | ProQR Therapeutics N.V. | $232.85M | $1.65 | — |
| SLGL | Sol-Gel Technologies Ltd. | $218.87M | $66.85 | — |
News headlines (Yahoo Finance, 1h cache)
1 Profitable Stock with Exciting Potential and 2 We Avoid
2026-09-17 08:26 · Yahoo
3 Small-Cap Stocks We Find Risky
2026-09-02 20:04 · Yahoo
1 Value Stock with Promising Prospects and 2 We Brush Off
2026-08-18 13:09 · Yahoo
3 Stocks Under $50 with Questionable Fundamentals
2026-08-16 12:29 · Yahoo
5 Insightful Analyst Questions From Nature's Sunshine’s Q2 Earnings Call
2026-08-15 15:57 · Yahoo
Nature's Sunshine (NATR) Q2 2026 Earnings Call Transcript
2026-08-14 15:50 · Yahoo
Nature's Sunshine (NATR) Stock Trades Down, Here Is Why
2026-08-10 23:33 · Yahoo
Natures Sunshine Products Inc (NATR) (Q2 2026) Earnings Call Highlights: Record Sales and ...
2026-08-07 05:05 · Yahoo
Nature's Sunshine Products Q2 Earnings Call Highlights
2026-08-07 05:04 · Yahoo
Nature's Sunshine Reports Second Quarter 2026 Results
2026-08-06 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.